{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:52:35Z","timestamp":1793836355272,"version":"4.6.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T00:00:00Z","timestamp":1674604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T00:00:00Z","timestamp":1674604800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"The Basic Scientific Research Projects of Wenzhou","award":["Y2020739"],"award-info":[{"award-number":["Y2020739"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-023-03312-y","type":"journal-article","created":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T09:03:14Z","timestamp":1674637394000},"page":"619-629","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Prevalence and impact of non-alcoholic fatty liver disease in patients with papillary thyroid carcinoma"],"prefix":"10.1007","volume":"80","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7679-0561","authenticated-orcid":false,"given":"Renyi","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3112-472X","authenticated-orcid":false,"given":"Chunjue","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yefeng","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yili","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohua","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6457-2046","authenticated-orcid":false,"given":"Keyue","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4657-6377","authenticated-orcid":false,"given":"Jie","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,25]]},"reference":[{"issue":"6","key":"3312_CR1","doi-asserted-by":"publisher","first-page":"686","DOI":"10.4158\/ep14466.dscr","volume":"21","author":"L Davies","year":"2015","unstructured":"L. Davies et al. American association of clinical endocrinologists and american college of endocrinology disease state clinical review: the increasing incidence of thyroid cancer. Endocr. Pract. 21(6), 686\u2013696 (2015). https:\/\/doi.org\/10.4158\/ep14466.dscr","journal-title":"Endocr. Pract."},{"issue":"1","key":"3312_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"R Siegel","year":"2022","unstructured":"R. Siegel et al. Cancer statistics, 2022. CA: Cancer J. Clin. 72(1), 7\u201333 (2022). https:\/\/doi.org\/10.3322\/caac.21708","journal-title":"CA: Cancer J. Clin."},{"issue":"1","key":"3312_CR3","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ecl.2018.10.002","volume":"48","author":"C Seib","year":"2019","unstructured":"C. Seib, J. Sosa, Evolving understanding of the epidemiology of thyroid cancer. Endocrinol. Metab. Clin. North Am. 48(1), 23\u201335 (2019). https:\/\/doi.org\/10.1016\/j.ecl.2018.10.002","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"3312_CR4","doi-asserted-by":"publisher","first-page":"5544232","DOI":"10.1155\/2021\/5544232","volume":"2021","author":"S Xu","year":"2021","unstructured":"S. Xu, Y. Han, The overdiagnosis of thyroid micropapillary carcinoma: the rising incidence, inert biological behavior, and countermeasures. J. Oncol. 2021, 5544232 (2021). https:\/\/doi.org\/10.1155\/2021\/5544232","journal-title":"J. Oncol."},{"issue":"3","key":"3312_CR5","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1158\/1055-9965.epi-08-0960","volume":"18","author":"L Enewold","year":"2009","unstructured":"L. Enewold et al. Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980\u20132005. Cancer Epidemiol. Biomark. Prev. 18(3), 784\u2013791 (2009). https:\/\/doi.org\/10.1158\/1055-9965.epi-08-0960","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"3","key":"3312_CR6","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1111\/dme.13565","volume":"35","author":"AL Sberna","year":"2018","unstructured":"A.L. Sberna et al. European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD) and European Association for the Study of Obesity (EASO) clinical practice recommendations for the management of non-alcoholic fatty liver disease: evaluation of their application in people with Type 2 diabetes. Diabet. Med. 35(3), 368\u2013375 (2018). https:\/\/doi.org\/10.1111\/dme.13565","journal-title":"Diabet. Med."},{"issue":"1","key":"3312_CR7","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Z.M. Younossi et al. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 64(1), 73\u201384 (2016). https:\/\/doi.org\/10.1002\/hep.28431","journal-title":"Hepatology"},{"issue":"7","key":"3312_CR8","doi-asserted-by":"publisher","first-page":"e1001680","DOI":"10.1371\/journal.pmed.1001680","volume":"11","author":"G Musso","year":"2014","unstructured":"G. Musso et al. Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis. PLoS Med. 11(7), e1001680 (2014). https:\/\/doi.org\/10.1371\/journal.pmed.1001680","journal-title":"PLoS Med."},{"issue":"25","key":"3312_CR9","doi-asserted-by":"publisher","first-page":"8102","DOI":"10.3748\/wjg.v20.i25.8102","volume":"20","author":"A Eshraghian","year":"2014","unstructured":"A. Eshraghian, A.Hamidian Jahromi, Non-alcoholic fatty liver disease and thyroid dysfunction: a systematic review. World J. Gastroenterol. 20(25), 8102\u20138109 (2014). https:\/\/doi.org\/10.3748\/wjg.v20.i25.8102","journal-title":"World J. Gastroenterol."},{"issue":"5","key":"3312_CR10","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1080\/08916934.2018.1488968","volume":"51","author":"Y Chen","year":"2018","unstructured":"Y. Chen et al. The association of non-alcoholic fatty liver disease with thyroid peroxidase and thyroglobulin antibody: a new insight from SPECT-China study. Autoimmunity 51(5), 238\u2013244 (2018). https:\/\/doi.org\/10.1080\/08916934.2018.1488968","journal-title":"Autoimmunity"},{"issue":"6","key":"3312_CR11","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1016\/j.jhep.2019.08.018","volume":"71","author":"AM Allen","year":"2019","unstructured":"A.M. Allen et al. The risk of incident extrahepatic cancers is higher in non-alcoholic fatty liver disease than obesity\u2014a longitudinal cohort study. J. Hepatol. 71(6), 1229\u20131236 (2019). https:\/\/doi.org\/10.1016\/j.jhep.2019.08.018","journal-title":"J. Hepatol."},{"issue":"6","key":"3312_CR12","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1136\/gut.2011.237974","volume":"60","author":"V Wong","year":"2011","unstructured":"V. Wong et al. High prevalence of colorectal neoplasm in patients with non-alcoholic steatohepatitis. Gut 60(6), 829\u2013836 (2011). https:\/\/doi.org\/10.1136\/gut.2011.237974","journal-title":"Gut"},{"key":"3312_CR13","doi-asserted-by":"publisher","unstructured":"G. Tarantino et al. Association of NAFLD and insulin resistance with non metastatic bladder cancer patients: a cross-sectional retrospective study. J Clin. Med. 10(2) (2021). https:\/\/doi.org\/10.3390\/jcm10020346","DOI":"10.3390\/jcm10020346"},{"issue":"4","key":"3312_CR14","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.cgh.2020.05.009","volume":"19","author":"Z Wang","year":"2021","unstructured":"Z. Wang et al. Associations between nonalcoholic fatty liver disease and cancers in a large cohort in China. Clin. Gastroenterol. Hepatol. 19(4), 788\u2013796.e4 (2021). https:\/\/doi.org\/10.1016\/j.cgh.2020.05.009","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"2","key":"3312_CR15","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/s1499-3872(16)60132-7","volume":"16","author":"SW Lee","year":"2017","unstructured":"S.W. Lee et al. The association of non-alcoholic fatty liver disease and metabolic syndrome in a Chinese population. Hepatobiliary Pancreat. Dis. Int. 16(2), 176\u2013180 (2017). https:\/\/doi.org\/10.1016\/s1499-3872(16)60132-7","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"key":"3312_CR16","doi-asserted-by":"publisher","first-page":"154770","DOI":"10.1016\/j.metabol.2021.154770","volume":"119","author":"E Muzurovi\u0107","year":"2021","unstructured":"E. Muzurovi\u0107, D.P. Mikhailidis, C. Mantzoros, Non-alcoholic fatty liver disease, insulin resistance, metabolic syndrome and their association with vascular risk. Metabolism 119, 154770 (2021). https:\/\/doi.org\/10.1016\/j.metabol.2021.154770","journal-title":"Metabolism"},{"issue":"3","key":"3312_CR17","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1007\/s12020-021-02940-6","volume":"75","author":"JL Song","year":"2022","unstructured":"J.L. Song et al. Association between metabolic syndrome and clinicopathological features of papillary thyroid cancer. Endocrine 75(3), 865\u2013871 (2022). https:\/\/doi.org\/10.1007\/s12020-021-02940-6","journal-title":"Endocrine"},{"key":"3312_CR18","doi-asserted-by":"publisher","first-page":"145754","DOI":"10.1155\/2012\/145754","volume":"2012","author":"M Obika","year":"2012","unstructured":"M. Obika, H. Noguchi, Diagnosis and evaluation of nonalcoholic fatty liver disease. Exp. Diabetes Res. 2012, 145754 (2012). https:\/\/doi.org\/10.1155\/2012\/145754","journal-title":"Exp. Diabetes Res."},{"key":"3312_CR19","doi-asserted-by":"publisher","unstructured":"EASL-EASD-EASO. Clinical practice guidelines for the management of non-alcoholic fatty liver disease. Obes. Facts, 2016. 9(2): 65\u201390, https:\/\/doi.org\/10.1159\/000443344","DOI":"10.1159\/000443344"},{"key":"3312_CR20","doi-asserted-by":"publisher","first-page":"154955","DOI":"10.1016\/j.metabol.2021.154955","volume":"127","author":"Z Liu","year":"2022","unstructured":"Z. Liu et al. Metabolic dysfunction-associated fatty liver disease and the risk of 24 specific cancers. Metabolism 127, 154955 (2022). https:\/\/doi.org\/10.1016\/j.metabol.2021.154955","journal-title":"Metabolism"},{"issue":"13","key":"3312_CR21","doi-asserted-by":"publisher","first-page":"3566","DOI":"10.1245\/s10434-011-1781-5","volume":"18","author":"G Howell","year":"2011","unstructured":"G. Howell et al. Both BRAF V600E mutation and older age (\u226565 years) are associated with recurrent papillary thyroid cancer. Ann. Surg Oncol. 18(13), 3566\u20133571 (2011). https:\/\/doi.org\/10.1245\/s10434-011-1781-5","journal-title":"Ann. Surg Oncol."},{"issue":"13","key":"3312_CR22","doi-asserted-by":"publisher","first-page":"3566","DOI":"10.1245\/s10434-011-1781-5","volume":"18","author":"GM Howell","year":"2011","unstructured":"G.M. Howell et al. Both BRAF V600E mutation and older age (\u226565 years) are associated with recurrent papillary thyroid cancer. Ann. Surg. Oncol. 18(13), 3566\u20133571 (2011). https:\/\/doi.org\/10.1245\/s10434-011-1781-5","journal-title":"Ann. Surg. Oncol."},{"key":"3312_CR23","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3389\/fendo.2019.00010","volume":"10","author":"F Yang","year":"2019","unstructured":"F. Yang et al. Survival in papillary thyroid microcarcinoma: a comparative analysis between the 7th and 8th versions of the AJCC\/UICC staging system based on the SEER database. Front. Endocrinol. 10, 10 (2019). https:\/\/doi.org\/10.3389\/fendo.2019.00010","journal-title":"Front. Endocrinol."},{"key":"3312_CR24","doi-asserted-by":"publisher","first-page":"3237","DOI":"10.2147\/cmar.s169741","volume":"10","author":"WX Jin","year":"2018","unstructured":"W.X. Jin et al. Prediction of central lymph node metastasis in papillary thyroid microcarcinoma according to clinicopathologic factors and thyroid nodule sonographic features: a case-control study. Cancer Manag. Res. 10, 3237\u20133243 (2018). https:\/\/doi.org\/10.2147\/cmar.s169741","journal-title":"Cancer Manag. Res."},{"issue":"5","key":"3312_CR25","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1089\/thy.2008.0185","volume":"19","author":"N Arora","year":"2009","unstructured":"N. Arora et al. Papillary thyroid carcinoma and microcarcinoma: is there a need to distinguish the two? Thyroid 19(5), 473\u2013477 (2009). https:\/\/doi.org\/10.1089\/thy.2008.0185","journal-title":"Thyroid"},{"issue":"1","key":"3312_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-11788-8","volume":"7","author":"C Liu","year":"2017","unstructured":"C. Liu et al. Reevaluating the prognostic significance of male gender for papillary thyroid carcinoma and microcarcinoma: a SEER database analysis. Sci. Rep. 7(1), 11412 (2017). https:\/\/doi.org\/10.1038\/s41598-017-11788-8","journal-title":"Sci. Rep."},{"issue":"1","key":"3312_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-60199-9","volume":"10","author":"J Ding","year":"2020","unstructured":"J. Ding et al. Male sex is associated with aggressive behaviour and poor prognosis in Chinese papillary thyroid carcinoma. Sci. Rep. 10(1), 4141 (2020). https:\/\/doi.org\/10.1038\/s41598-020-60199-9","journal-title":"Sci. Rep."},{"issue":"2","key":"3312_CR28","doi-asserted-by":"publisher","first-page":"142","DOI":"10.14639\/0392-100x-n1081","volume":"41","author":"FM Hanege","year":"2021","unstructured":"F.M. Hanege et al. Hashimoto\u2019s thyroiditis in papillary thyroid carcinoma: a 22-year study. Acta Otorhinolaryngol. Ital. 41(2), 142\u2013145 (2021). https:\/\/doi.org\/10.14639\/0392-100x-n1081","journal-title":"Acta Otorhinolaryngol. Ital."},{"issue":"8","key":"3312_CR29","first-page":"1786","volume":"9","author":"S Dong","year":"2019","unstructured":"S. Dong et al. Indicators of multifocality in papillary thyroid carcinoma concurrent with Hashimoto\u2019s thyroiditis. Am. J. Cancer Res. 9(8), 1786\u20131795 (2019)","journal-title":"Am. J. Cancer Res."},{"issue":"7","key":"3312_CR30","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","volume":"24","author":"SL Friedman","year":"2018","unstructured":"S.L. Friedman et al. Mechanisms of NAFLD development and therapeutic strategies. Nat. Med. 24(7), 908\u2013922 (2018). https:\/\/doi.org\/10.1038\/s41591-018-0104-9","journal-title":"Nat. Med."},{"issue":"24","key":"3312_CR31","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.2174\/092986705774454715","volume":"12","author":"A Ciampolillo","year":"2005","unstructured":"A. Ciampolillo, C. De Tullio, F. Giorgino, The IGF-I\/IGF-I receptor pathway: implications in the pathophysiology of thyroid cancer. Curr. Med. Chem. 12(24), 2881\u20132891 (2005). https:\/\/doi.org\/10.2174\/092986705774454715","journal-title":"Curr. Med. Chem."},{"issue":"6","key":"3312_CR32","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.21873\/anticanres.13409","volume":"39","author":"AK Karagiannis","year":"2019","unstructured":"A.K. Karagiannis et al. IGF-IEc expression is associated with advanced differentiated thyroid cancer. Anticancer Res. 39(6), 2811\u20132819 (2019). https:\/\/doi.org\/10.21873\/anticanres.13409","journal-title":"Anticancer Res."},{"issue":"4","key":"3312_CR33","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.beem.2008.08.009","volume":"22","author":"S Hursting","year":"2008","unstructured":"S. Hursting et al. Reducing the weight of cancer: mechanistic targets for breaking the obesity-carcinogenesis link. Best. Pract. Res. Clin. Endocrinol. Metab. 22(4), 659\u2013669 (2008). https:\/\/doi.org\/10.1016\/j.beem.2008.08.009","journal-title":"Best. Pract. Res. Clin. Endocrinol. Metab."},{"key":"3312_CR34","doi-asserted-by":"publisher","first-page":"314","DOI":"10.3389\/fendo.2017.00314","volume":"8","author":"R Malaguarnera","year":"2017","unstructured":"R. Malaguarnera et al. Insulin resistance: any role in the changing epidemiology of thyroid cancer? Front. Endocrinol. 8, 314 (2017). https:\/\/doi.org\/10.3389\/fendo.2017.00314","journal-title":"Front. Endocrinol."},{"issue":"5","key":"3312_CR35","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.dld.2020.10.025","volume":"53","author":"Q Zhang","year":"2021","unstructured":"Q. Zhang et al. Leptin induces NAFLD progression through infiltrated CD8+ T lymphocytes mediating pyroptotic-like cell death of hepatocytes and macrophages. Dig. Liver Dis. 53(5), 598\u2013605 (2021). https:\/\/doi.org\/10.1016\/j.dld.2020.10.025","journal-title":"Dig. Liver Dis."},{"key":"3312_CR36","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3389\/fphys.2013.00275","volume":"4","author":"V Catal\u00e1n","year":"2013","unstructured":"V. Catal\u00e1n et al. Adipose tissue immunity and cancer. Front. Physiol. 4, 275 (2013). https:\/\/doi.org\/10.3389\/fphys.2013.00275","journal-title":"Front. Physiol."},{"issue":"4","key":"3312_CR37","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/s1015-9584(09)60397-3","volume":"32","author":"M Akinci","year":"2009","unstructured":"M. Akinci et al. Leptin levels in thyroid cancer. Asian J. Surg. 32(4), 216\u2013223 (2009). https:\/\/doi.org\/10.1016\/s1015-9584(09)60397-3","journal-title":"Asian J. Surg."},{"issue":"6","key":"3312_CR38","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.surg.2009.11.004","volume":"147","author":"S Cheng","year":"2010","unstructured":"S. Cheng et al. Clinicopathologic significance of leptin and leptin receptor expressions in papillary thyroid carcinoma. Surgery 147(6), 847\u2013853 (2010). https:\/\/doi.org\/10.1016\/j.surg.2009.11.004","journal-title":"Surgery"},{"issue":"1","key":"3312_CR39","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1002\/hep.20280","volume":"40","author":"JM Hui","year":"2004","unstructured":"J.M. Hui et al. Beyond insulin resistance in NASH: TNF-alpha or adiponectin? Hepatology 40(1), 46\u201354 (2004). https:\/\/doi.org\/10.1002\/hep.20280","journal-title":"Hepatology"},{"issue":"12","key":"3312_CR40","doi-asserted-by":"publisher","first-page":"E2023","DOI":"10.1210\/jc.2010-1908","volume":"96","author":"N Mitsiades","year":"2011","unstructured":"N. Mitsiades et al. Circulating adiponectin is inversely associated with risk of thyroid cancer: in vivo and in vitro studies. J. Clin. Endocrinol. Metab. 96(12), E2023\u2013E2028 (2011). https:\/\/doi.org\/10.1210\/jc.2010-1908","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"3312_CR41","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1002\/jgh3.12264","volume":"4","author":"K Tahara","year":"2020","unstructured":"K. Tahara et al. Thyroid-stimulating hormone is an independent risk factor of non-alcoholic fatty liver disease. JGH Open 4(3), 400\u2013404 (2020). https:\/\/doi.org\/10.1002\/jgh3.12264","journal-title":"JGH Open"},{"issue":"5","key":"3312_CR42","doi-asserted-by":"publisher","first-page":"T255","DOI":"10.1530\/erc-14-0070","volume":"21","author":"M Marcello","year":"2014","unstructured":"M. Marcello et al. Obesity and thyroid cancer. Endocr.-Relat. Cancer 21(5), T255\u2013T271 (2014). https:\/\/doi.org\/10.1530\/erc-14-0070","journal-title":"Endocr.-Relat. Cancer"},{"issue":"5","key":"3312_CR43","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.jhep.2012.11.021","volume":"58","author":"M Machado","year":"2013","unstructured":"M. Machado, H. Cortez-Pinto, Non-invasive diagnosis of non-alcoholic fatty liver disease. a critical appraisal. J. Hepatol. 58(5), 1007\u20131019 (2013). https:\/\/doi.org\/10.1016\/j.jhep.2012.11.021","journal-title":"J. Hepatol."},{"issue":"4","key":"3312_CR44","doi-asserted-by":"publisher","first-page":"290","DOI":"10.3350\/cmh.2017.0042","volume":"23","author":"DH Lee","year":"2017","unstructured":"D.H. Lee, Imaging evaluation of non-alcoholic fatty liver disease: focused on quantification. Clin. Mol. Hepatol. 23(4), 290\u2013301 (2017). https:\/\/doi.org\/10.3350\/cmh.2017.0042","journal-title":"Clin. Mol. Hepatol."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-023-03312-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-023-03312-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-023-03312-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T14:47:19Z","timestamp":1744210039000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-023-03312-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,25]]},"references-count":44,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,6]]}},"alternative-id":["3312"],"URL":"https:\/\/doi.org\/10.1007\/s12020-023-03312-y","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,25]]},"assertion":[{"value":"6 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The studies involving human participants were reviewed and approved by ethics committee of the First Affiliated Hospital of Wenzhou Medical University.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The participants provided their written informed consent to participate in this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}